您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > RN486
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
RN486
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
RN486图片
CAS NO:1242156-23-5
包装与价格:
包装价格(元)
10mM (in 1mL DMSO)电议
5mg电议
25mg电议

产品介绍
RN486 是一种有效的、选择性的、具有口服活性的 Btk 抑制剂,IC50 为 4.0 nM,Kd 为 0.31 nM。
Cas No.1242156-23-5
化学名6-cyclopropyl-8-fluoro-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(4-methylpiperazin-1-yl)pyridin-2-yl]amino]-6-oxopyridin-3-yl]phenyl]isoquinolin-1-one
Canonical SMILESCN1CCN(CC1)C2=CN=C(C=C2)NC3=CC(=CN(C3=O)C)C4=C(C(=CC=C4)N5C=CC6=CC(=CC(=C6C5=O)F)C7CC7)CO
分子式C35H35FN6O3
分子量606.69
溶解度≥ 30.35mg/mL in DMSO with gentle warming
储存条件Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

RN486 is a reversible inhibitor of Btk with IC50 value of 4.0 nM [1].
Bruton's tyrosine kinase (Btk) is a type of kinase protein which is expressed by immune system-related cells (B-lymphocyte, monocytes, macrophages, neutrophils and mast cells) and plays a pivotal role in cell differentiation and proliferation at the transition from pre-B to later B cell stages as well as in the process of both BCR and FcR signaling [2]. It has been reported that aberrant BCR signaling is associated with autoimmune diseases, for example, rheumatoid arthritis (RA) [3].
RN486 is a selective Btk inhibitor. When tested with human Ramos B cells or whole blood, RN486 treatment reduced the expression of CD69/B cells proliferation and IgG production by blocking BCR and FcR Signaling [1].
In NZB × NZW mouse model with systemic lupus erythematosus (SLE), compared with control group, RN486 treatment completely stopped disease progression by inhibiting BTK signaling and targeting other autoantibody-producing and effector cells [4]. In a PCA (type I hypersensitivity) mouse model or rPCA (type III hypersensitivity) mouse model, RN486 treatment significantly inhibited inflammatory response. In mouse model of RA, administration of RN486 orally could reduce both paw swelling and inflammatory markers in the blood by inhibiting both joint and systemic inflammation alone or in combination with methotrexate [1].
RN486 may also play a pivotal role in reducing immune complex-mediated activation of human monocytes and down-regulating the expression of macrophage-related and interferon-inducible genes [4].
References:
[1].    Xu, D., et al., RN486, a selective Bruton's tyrosine kinase inhibitor, abrogates immune hypersensitivity responses and arthritis in rodents. J Pharmacol Exp Ther, 2012. 341(1): p. 90-103.
[2].    Kil, L.P., et al., Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice. Blood, 2012. 119(16): p. 3744-56.
[3].    Hartkamp, L.M., et al., Btk inhibition suppresses agonist-induced human macrophage activation and inflammatory gene expression in RA synovial tissue explants. Ann Rheum Dis, 2014.
[4].    Mina-Osorio, P., et al., Suppression of glomerulonephritis in lupus-prone NZB x NZW mice by RN486, a selective inhibitor of Bruton's tyrosine kinase. Arthritis Rheum, 2013. 65(9): p. 2380-91.